SENSEX    73651.35       655.04    |    NIFTY    22326.9       203.25 FAQ    |    Feedback
EQUITIES
DERIVATIVES
IPO
Gainers & Losers Value & Volume Toppers 52 Weeks High/Low Advances & Declines
New High-Low
Pre-Session Mid-Session End-Session Other Markets Market Beat Stock Alert
Hot Pursuit Foreign Markets Economy News Corporate News Corporate Results
Detailed Quotes Board of Directors Balance Sheet Profit & Loss Quarterly Results Historical Price
Financial Ratios Company Background Technical Chart
Announcements Book Closure Board Meetings Bonus Issues Rights Issues
De-Listed Shares Name Change Split of Face Value Market Turnover
FII Investments MF Investments ADR Prices World Indices
Forthcoming IPOs
Open IPOs
Closed IPOs
New Listing
Basis Of Allotment Draft Prospectus New Issue Monitor
Get Quotes
Gainers
Losers
Value Toppers Advances & Declines Ticker Spot
Ticker Futures Closing Price Technical Chart Commodity News MCX Currency Futures
Get Quotes NIFTY Futures Top Traded Value Top Quantity Most Active Contracts
FII Statistics Daily Settlement Price List of Underlyings Put Call Ratio Derivative Summary
All Index Futures Top Gainers Top Losers Most Active Put Most Active Call
Highest in OI Lowest in OI Increase in OI Decrease in OI
IPO Synopsis
Rossari Biotech Ltd
Registered Office: 201 A-B 2nd Floor LBS Marg,Akruti Corporate Park Kanjur(W, Mumbai - 400079, Maharashtra, India.
Phone : 91-22-6123 3800   Fax:91-22-2579 6982
Email :  cs@rossarimail.com  
Website :  www.rossari.com
Initial Public Offering of 11,676,470 equity shares of face value of Rs. 2 each ("equity shares") of Rossari Biotech Limited (the "company" or the "issuer") for cash at a price of Rs. 425 per equity share (including a share premium of Rs. 423 per equity share) (the "offer price") aggregating to Rs. 496.25 Crores comprising a fresh issue of 1,176,470 equity shares aggregating to Rs. 50* Crores (the "fresh issue") and an offer for sale of 10,500,000 equity shares (the "offered shares") aggregating to Rs. 44.63 Crores, comprising an offer for sale of 5,250,000 equity shares aggregating to Rs. 22.31 Crores by Mr. Edward Menezes and 5,250,000 equity shares aggregating to Rs. 22.31 Crores by Mr. Sunil Chari (the "promoter selling shareholders" or the "selling shareholders"), (the "offer for sale", and together with the fresh issue, the "offer"). The offer shall constitute 22.49% of the post-offer paid up equity share capital of the company. The company has, in consultation with the book running lead managers ("brlms"), undertaken a private placement of equity shares aggregating to Rs. 99.999 Crores ("pre-ipo placement"). The size of the fresh issue of up to Rs. 150 Crores has been reduced by Rs. 99.999 Crores pursuant to the pre-ipo placement and accordingly, the size of the fresh issue is up to Rs. 50. Crores
Issue Money Payable On
Opens On Closes On Application Allotment
13-Jul-20 15-Jul-20 425.00-0.00 0.00-0.00
Minimum Application for shares in Nos : 35   Further Multiples of : 35
  Rs Cr Lead Managers to the Issue
Project Cost 0.00 Axis Capital Ltd
Project Financed through Current Offer 496.25  
Post Issue Equity Share Capital 10.39  
Issue Price 425.00  
Projects
Repayment/Prepayment of certain Indebtedness availed by the company (including accrued Interest) Funding Working Capital Requirements
General Corporate Purposes
Promoted By
Edward Walter Menezes
Sunil Srinivasan Chari
Listing At
BSE
NSE
Registrar to the Issue
No Data Available
MARKETS
TODAY'S MARKET SECTOR
BSE NSE
Currencies
Currency EUR GBP INR USD
Europe (EUR) 1.00 0.86 90.21 1.08
United Kingdom (GBP) 1.17 1.00 105.20 1.26
India (INR) 0.01 0.01 1.00 0.01
United States (USD) 0.92 0.79 83.34 1.00
Market News << ALL News
  29-Mar-2024, (01:08 )  RVNL emerges as L-1 ..
  29-Mar-2024, (12:33 )  Macrotech Developers..
  29-Mar-2024, (11:47 )  Asian Paints to infu..
  29-Mar-2024, (11:16 )  CRISIL upgrades outl..
 Commodities << ALL Commodities
   Attention Investor: Prevent unauthorized transactions in your trading / Demat account : Update your mobile number / e mail ids with your stock broker / deposit." | "No need to issue cheques by investors while subscribing to IPO.Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor’s account." | "KYC is one time exercise while dealing in securities markets- once KYC is done through a SEBI registered intermediary(broker, DP, Mutual Fund etc.) you need not undergo the same process again when you approach another intermediary."
   Disclaimer   |   BSE Disclosure  |  Privacy Policy   |   Investor Protection   |    Inactive Account   |  Vernacular Language: NSE | BSE   |   Feedback   |    PMLA Policy   |   Risk Management Policy   |   Insider Trading   |   Investor Grivenances   |   Investor Complaints   |   Investor Charter   |   Rules And Regulations   |   Broker Norms   |   Terms of Use    Policies & Procedures   |   Risk Disclosure   |   Do & Don’ts   |   Rights & Obligations
  
SEBI Registration No : INZ000267132   |   BSE Clearing No : 333   
   Copyright © 2011 All rights reserved by Jaysukhlal Jagjivan Stock Broking Pvt.Ltd Designed, Developed & Powered By CMOTS INFOTECH (ISO 9001:2015 certified)